Jefferies analyst issues SELL recommendation for NFLX on October 2, 2026 06:35PM ET. The previous analyst recommendation was Buy.NFLX was trading at $67.0477 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current analyst recommendations are : 64 - Buy, 29 - Hold, 7 - Sell recommendations .Historical Analyst RecommendationsLatest 10 recommendationsReport DateAnalyst CompanyActionPrevious...
KeyBanc analyst issues OVERWEIGHT recommendation for NFLX on October 2, 2026 06:35PM ET. The previous analyst...
Citigroup analyst issues SELL recommendation for NFLX on October 2, 2026 06:35PM ET. The previous analyst...
Goldman Sachs analyst issues OVERWEIGHT recommendation for NKE on October 2, 2026 08:41PM ET. The previous...
HSBC analyst issues BUY recommendation for NFLX on October 2, 2026 06:35PM ET. The previous analyst...
from Scotiabank issued a price target of $27.50 for CMCSA on 2026-10-02 13:51:42.The adjusted price target was set to $27.50.At the time of the announcement, CMCSA was trading at $21.7099.The...
Jay Sole from UBS issued a price target of $34.00 for NKE on 2026-10-02 13:42:03.The adjusted price target was set to $34.00.At the time of the announcement, NKE was trading...
Angie Storozynski from Seaport Global issued a price target of $56.00 for NEE on 2026-10-02 13:36:59.The adjusted price target was set to $56.00.At the time of the announcement, NEE was...
Michael Binetti from Evercore ISI issued a price target of $28.00 for NKE on 2026-10-02 12:02:26.The adjusted price target was set to $28.00.At the time of the announcement, NKE was...
from Susquehanna issued a price target of $70.00 for HPE on 2026-10-02 12:00:18.The adjusted price target was set to $70.00.At the time of the announcement, HPE was trading at $68.5674.The...
In the first quarter of 2025, the company faced revenue declines, largely due to Paxlovid, while operational expenses surged. Management is committed to enhancing R&D productivity and optimizing capital allocation,...
In a landscape of fluctuating markets and regulatory uncertainties, the company experienced a remarkable revenue surge, reaching $36,077 million. Despite operational challenges, net income stood at $7,713 million. Management emphasized...
In the bustling corridors of Merck, management reflects on a transformative quarter. With net income rising to 5,085 million, the company celebrates strategic wins in oncology and diabetes, driven by...
In 2025, the company embraced growth through increased research and development, despite rising operating expenses. A net income of $24,780 million marked a decline, reflecting challenges in a fluctuating market....
In the first quarter of 2025, the company experienced a 9% revenue growth, fueled by increased sales and services. Operating expenses rose, reflecting evolving cost structures, while net income showed...
Amazon.com (AMZN) and Microsoft (MSFT) are poised to navigate a landscape of increasing regulatory scrutiny in Europe, as regulators seek to rein in the power wielded by major cloud service...
Tesla Inc. (NASDAQ:TSLA) surprised the market with strong third-quarter delivery figures, announcing that it delivered 486,532 vehicles in Q3 2026, a notable increase that eclipsed its production numbers of 464,391...
On October 2, 2026, Nvidia Corp. (NASDAQ: NVDA) reached a new all-time high (ATH) stock price of $237.55, benefitting from robust fundamentals that are capturing investor attention. The stellar performance...
Micron Technology, Inc. has recently shown remarkable growth, predominantly attributed to an unprecedented surge in memory prices, prompting a complex mix of optimism and caution among analysts and investors alike....
In a notable development within the semiconductor industry, shares of Taiwan Semiconductor Manufacturing Co. (NYSE: TSM) experienced an uptick on Friday, largely buoyed by optimism in the broader chip market....
